Four Phase 3 clinical trials of baricitinib in the treatment of moderate-to-severe active rheumatoid arthritis enrolled patients who were methotrexate-naïve or had inadequate response to methotrexate, conventional disease-modifying antirheumatic drugs (DMARDs) or DMARDs with TNF inhibitors.
Your search for oral corticosteroids returned 21 results
Ranolazine, an antianginal drug, has been added as a new contraindication. The labeling states that concomitant use has potential for serious and/or life-threatening reactions.
The data revealed the most common indications for short-term corticosteroid use to be upper respiratory tract infections, spinal conditions, and allergies.
Based on the pathophysiological and clinical characteristics of N-ERD, anti-IL 5 therapy may be effective in this patient subgroup.
The recommendations are intended for all clinicians treating adult patients with acute, suabcute, or chronic low back pain.
The Food and Drug Administration (FDA) has approved supplemental Biologics License Applications (sBLA) for Amgen’s Prolia (denosumab) and Xgeva (denosumab).
Treatment with oral dexamethasone for 4 days significantly improved pain levels in the majority of outpatients with status migrainosus, a retrospective chart review presented at the 68th AAN Annual Meeting has found.
A recent online survey has found that physicians in the United States tend to prefer weekly or monthly regimens when prescribing treatment for patients with osteoporosis.
An analysis published in the Journal of Clinical Pharmacy and Therapeutics of asthma medication adherence showed poor coverage across a six-month period.
Capsaicin may be a treatment option for patients with idiopathic non-allergic rhinitis, concluded study authors from the Cochrane Ears, Nose and Throat Group.